Wiseguyreports.Com Adds “Global Halal Pharmaceuticals Market Insights, Forecast to 2025” To Its Research Database
Halal Pharmaceuticals Market 2025
Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as ‘haram’ under the Shariah law.
Scope of the Report:
In the last several years, global market of Halal Pharmaceuticals developed rapidly, with an average growth rate of 22.98%. In the next few years, Halal Pharmaceuticals industry will maintain increasing at a high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
Southeast Asia and NAME is the main production places, with a revenue market share nearly 62% and 18% in 2016. Southeast Asia and NAME also is the main consumption region with market share 58% and 26% in 2016. The revenue is about 205.79 M USD the consumption need is around 36.7 B USD in 2016 and there is a huge gap in there.
The classification of Halal Pharmaceuticals includes Tablets, Syrups, Capsules and Other. The proportion of Tablets in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
The global Halal Pharmaceuticals market is valued at 240 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 12.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Halal Pharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Halal Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Halal Pharmaceuticals in these regions.
This research report categorizes the global Halal Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Halal Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The key players covered in this study
Market size by Product
Market size by End User
Health Care Products
Market size by Region
The study objectives of this report are:
To study and analyze the global Halal Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Halal Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Halal Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Halal Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Major Key Points in Table of Content:
1 Study Coverage
1.1 Halal Pharmaceuticals Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Halal Pharmaceuticals Market Size Growth Rate by Product
1.5 Market by End User
1.5.1 Global Halal Pharmaceuticals Market Size Growth Rate by End User
1.5.2 Health Care Products
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Halal Pharmaceuticals Market Size
2.1.1 Global Halal Pharmaceuticals Revenue 2014-2025
2.1.2 Global Halal Pharmaceuticals Sales 2014-2025
2.2 Halal Pharmaceuticals Growth Rate by Regions
2.2.1 Global Halal Pharmaceuticals Sales by Regions
2.2.2 Global Halal Pharmaceuticals Revenue by Regions
12 International Players Profiles
12.1.1 Kronos Company Details
12.1.2 Company Description and Business Overview
12.1.3 Halal Pharmaceuticals Introduction
12.1.4 Kronos Revenue in Halal Pharmaceuticals Business (2014-2019)
12.1.5 Kronos Recent Development
12.2.1 Infor Company Details
12.2.2 Company Description and Business Overview
12.2.3 Halal Pharmaceuticals Introduction
12.2.4 Infor Revenue in Halal Pharmaceuticals Business (2014-2019)
12.2.5 Infor Recent Development
12.3.1 Oracle Company Details
12.3.2 Company Description and Business Overview
12.3.3 Halal Pharmaceuticals Introduction
12.3.4 Oracle Revenue in Halal Pharmaceuticals Business (2014-2019)
12.3.5 Oracle Recent Development
12.4 GE Healthcare (Api Healthcare)
12.4.1 GE Healthcare (Api Healthcare) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Halal Pharmaceuticals Introduction
12.4.4 GE Healthcare (Api Healthcare) Revenue in Halal Pharmaceuticals Business (2014-2019)
12.4.5 GE Healthcare (Api Healthcare) Recent Development
12.5.1 McKesson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Halal Pharmaceuticals Introduction
12.5.4 McKesson Revenue in Halal Pharmaceuticals Business (2014-2019)
12.5.5 McKesson Recent Development
12.6 Allocate Software
12.6.1 Allocate Software Company Details
12.6.2 Company Description and Business Overview
12.6.3 Halal Pharmaceuticals Introduction
12.6.4 Allocate Software Revenue in Halal Pharmaceuticals Business (2014-2019)
12.6.5 Allocate Software Recent Development
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)